Earnings call transcript: Daktronics beats Q4 2026 profit views, shares rise

Daktronics delivered a strong fiscal Q4 with adjusted EPS of $0.27 versus $0.21 expected and revenue of $208.61 million versus $207.50 million, while full-year revenue hit a record $839 million, up 10.9%. Adjusted operating margin expanded 290 bps to 7.3% and full-year adjusted EPS rose 25% to $1.05, supported by a $356 million backlog and continued buybacks. Shares rose 2.14% premarket as management reaffirmed fiscal 2028 targets and highlighted growth initiatives including Camino 8 and the Mexico plant ramp.

Analysis

DAKT is showing the classic inflection pattern we like: backlog is translating into margin, not just revenue. The bigger signal is that pricing, mix discipline, and manufacturing footprint optimization are starting to compound; that means competitors without scale or a flexible supply chain will have to chase volume at lower returns, especially in commercial out-of-home where pricing pressure remains intense. The Mexico ramp is less a near-term earnings booster than a capacity-release valve, which should let Daktronics take share in tighter-installation windows where execution speed matters more than sticker price.

The second-order effect is on working capital and cash conversion. If management is right that the Q4 cash drain reverses early in FY27, the stock can rerate quickly because the market is currently underweighting the combination of earnings growth plus operating cash flow normalization. That makes the next 1-2 quarters the key catalyst window: if backlog converts at the implied rate and gross margin holds in the high-20s, the market will start anchoring to the FY28 margin target rather than treating it as aspirational.

The contrarian view is that consensus may be overestimating how smooth this step-up will be. This is still a project business with lumpy revenue timing, and the new facility, automation, and software initiatives are all initially cost/complexity adds before they become benefits. If bookings slow even modestly or a few large installs slip, the stock can give back quickly because the current move already prices in cleaner execution.

Net: the setup is constructive, but the better trade is not chasing the open — it is owning the next pullback or using optionality into the FY27 conversion window. The key is whether the company can sustain order momentum while proving that the margin structure is structurally higher, not just temporarily helped by timing and pricing actions.

Key Decisions for Investors

• Long DAKT on pullbacks over the next 2-6 weeks; target a re-rate toward the upper end of the 52-week range if FY27 backlog conversion and cash flow normalization show up, with downside anchored by balance sheet strength.
• Buy DAKT call spreads into the next quarterly print / FY27 guidance updates; the best upside is a multiple expansion if gross margin holds near the high-20s and operating cash flow turns back positive.
• Pair trade: long DAKT / short a weaker-capitalized small-cap industrial or display peer with less pricing power and less capacity flexibility; thesis is that execution and balance sheet quality will widen the gap over 2-3 quarters.
• If already long, trim into strength above the recent premarket move and re-add only if management proves backlog-to-revenue conversion is tracking; this is a lumpy name and entry discipline matters.
• For risk-managed exposure, use a 3-6 month time horizon and size for project-timing volatility; the trade works only if FY27 is a bridge year to FY28 margin expansion rather than a peak-growth year.